North America Coagulation Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Coagulation Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Coagulation Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Coagulation Market Regional Analysis

6.2 North America Coagulation Market Revenue 2020-2030 (US$ Million)

6.3 North America Coagulation Market Forecast Analysis

7. North America Coagulation Market Analysis – by Disease Indications

7.1 Vitamin K Deficiency

7.1.1 Overview
7.1.2 Vitamin K Deficiency: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Liver Disease

7.2.1 Overview
7.2.2 Liver Disease: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Disseminated Intravascular Coagulation & Pulmonary Embolism

7.3.1 Overview
7.3.2 Disseminated Intravascular Coagulation & Pulmonary Embolism: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.4 Development of Circulating Anticoagulants

7.4.1 Overview
7.4.2 Development of Circulating Anticoagulants: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.5 Hemophilia

7.5.1 Overview
7.5.2 Hemophilia: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.6 Von Willebrand\'s Disease

7.6.1 Overview
7.6.2 Von Willebrand\'s Disease: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Coagulation Market Analysis – by Type

8.1 Clinical Laboratory Analyzers

8.1.1 Overview
8.1.2 Clinical Laboratory Analyzers: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Point-of-Care Testing Analyzers

8.2.1 Overview
8.2.2 Point-of-Care Testing Analyzers: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Coagulation Market Analysis – by Offering

9.1 Prothrombin Time Testing

9.1.1 Overview
9.1.2 Prothrombin Time Testing: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Fibrinogen Testing

9.2.1 Overview
9.2.2 Fibrinogen Testing: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Activated Clotting Time Testing

9.3.1 Overview
9.3.2 Activated Clotting Time Testing: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.4 Activated Partial Thromboplastin Time Testing

9.4.1 Overview
9.4.2 Activated Partial Thromboplastin Time Testing: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.5 D-Dimmer Testing

9.5.1 Overview
9.5.2 D-Dimmer Testing: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.6 Platelets Function Testing

9.6.1 Overview
9.6.2 Platelets Function Testing: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. North America Coagulation Market Analysis – by Treatment

10.1 Anti-Fibrinolytic Drugs

10.1.1 Overview
10.1.2 Anti-Fibrinolytic Drugs: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Birth Control Pills

10.2.1 Overview
10.2.2 Birth Control Pills: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.3 Desmopressin & Immunosuppressive Medicines

10.3.1 Overview
10.3.2 Desmopressin & Immunosuppressive Medicines: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.4 Vitamin K Supplements

10.4.1 Overview
10.4.2 Vitamin K Supplements: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.5 Blood Thinners

10.5.1 Overview
10.5.2 Blood Thinners: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.6 Thrombin Inhibitors or Thrombolytics

10.6.1 Overview
10.6.2 Thrombin Inhibitors or Thrombolytics: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.7 Replacement Therapy

10.7.1 Overview
10.7.2 Replacement Therapy: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.8 Catheter-Assisted Thrombus Removal

10.8.1 Overview
10.8.2 Catheter-Assisted Thrombus Removal: North America Coagulation Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. North America Coagulation Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Coagulation Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 North America Coagulation Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 US: North America Coagulation Market Breakdown, by Disease Indications
11.2.1.1.2 US: North America Coagulation Market Breakdown, by Type
11.2.1.1.3 US: North America Coagulation Market Breakdown, by Offering
11.2.1.1.4 US: North America Coagulation Market Breakdown, by Treatment

11.2.1.2 Canada: North America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Canada: North America Coagulation Market Breakdown, by Disease Indications
11.2.1.2.2 Canada: North America Coagulation Market Breakdown, by Type
11.2.1.2.3 Canada: North America Coagulation Market Breakdown, by Offering
11.2.1.2.4 Canada: North America Coagulation Market Breakdown, by Treatment

11.2.1.3 Mexico : North America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 Mexico : North America Coagulation Market Breakdown, by Disease Indications
11.2.1.3.2 Mexico : North America Coagulation Market Breakdown, by Type
11.2.1.3.3 Mexico : North America Coagulation Market Breakdown, by Offering
11.2.1.3.4 Mexico : North America Coagulation Market Breakdown, by Treatment

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Diagnostica Stago, Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 F. Hoffmann-La Roche Ltd

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Genrui Biotech Co., Ltd

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Helena Laboratories Corporation

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Horiba Ltd.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 ImproGen Diagnostik Kimya San. & Tic. Ltd. ti

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Siemens Healthineers AG

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Sysmex Corp

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Transasia Bio-Medicals Ltd

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Coagulation Market